Published in:
Open Access
01-11-2010 | Poster presentation
Influence of variants of Fcg receptor IIA on the European league against rheumatism responses to anti-tumour necrosis factor alpha therapy in psoriatic arthritis
Authors:
J Ramirez, J L Fernadez-Sueiro, R Lopez, C Montilla, B Suarez, C Moll, R Rodriguez, F Blanco, M Alsina, R Sanmarti, F Lozano, J Cañete
Published in:
Journal of Translational Medicine
|
Special Issue 1/2010
Login to get access
Excerpt
The efficacy of biological therapies currently used in psoriatic arthritis depends not only on their blocking effect on the targeted molecule but also on the affinity of genetically defined variants of the Fc-gamma receptors for the constant portion (Fc fragment of IgG1). …